Reproducibility measurement of glutathione, GABA, and glutamate: Towards in vivo neurochemical profiling of multiple sclerosis with MR spectroscopy at 7T

To determine the reproducibility of a comprehensive single‐session measurement of glutathione (GSH), γ‐aminobutyric acid (GABA), glutamate, and other biochemicals implicated in the pathophysiology of multiple sclerosis (MS) in the human brain with 1H magnetic resonance spectroscopy (MRS).

[1]  Gülin Öz,et al.  Regional neurochemical profiles in the human brain measured by 1H MRS at 7 T using local B1 shimming , 2012, NMR in biomedicine.

[2]  K. Behar,et al.  Analysis of macromolecule resonances in 1H NMR spectra of human brain , 1994, Magnetic resonance in medicine.

[3]  James S Hodges,et al.  Sensitivity and specificity of human brain glutathione concentrations measured using short‐TE 1H MRS at 7 T , 2016, NMR in biomedicine.

[4]  K. Behar,et al.  13C MRS studies of neuroenergetics and neurotransmitter cycling in humans , 2011, NMR in biomedicine.

[5]  Kamil Ugurbil,et al.  Noninvasive quantification of human brain ascorbate concentration using 1H NMR spectroscopy at 7 T , 2010, NMR in biomedicine.

[6]  Karl Young,et al.  Numerical simulations of localized high field 1H MR spectroscopy. , 2008, Journal of magnetic resonance.

[7]  Paul M Matthews,et al.  Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis. , 2010, Brain : a journal of neurology.

[8]  Rolf Gruetter,et al.  Localized short‐echo‐time proton MR spectroscopy with full signal‐intensity acquisition , 2006, Magnetic resonance in medicine.

[9]  R. Kreis,et al.  Identification and quantitation of phenylalanine in the brain of patients with phenylketonuria by means of localized in vivo 1H magnetic-resonance spectroscopy. , 1995, Journal of magnetic resonance. Series B.

[10]  K Ugurbil,et al.  In vivo 1H NMR spectroscopy of the human brain at 7 T , 2001, Magnetic resonance in medicine.

[11]  T. Scheenen,et al.  Multi‐center reproducibility of neurochemical profiles in the human brain at 7 T , 2015, NMR in biomedicine.

[12]  Michael Garwood,et al.  Localized 1H NMR spectroscopy in different regions of human brain in vivo at 7 T: T2 relaxation times and concentrations of cerebral metabolites , 2012, NMR in biomedicine.

[13]  Rolf Gruetter,et al.  Net increase of lactate and glutamate concentration in activated human visual cortex detected with magnetic resonance spectroscopy at 7 tesla , 2013, Journal of neuroscience research.

[14]  D Matthaei,et al.  1H NMR chemical shift selective (CHESS) imaging. , 1985, Physics in medicine and biology.

[15]  S. Provencher.  Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.

[16]  G Helms,et al.  Regression analysis of metabolite concentrations estimated from localized proton MR spectra of active and chronic multiple sclerosis lesions , 2000, Magnetic resonance in medicine.

[17]  U. Klose.  In vivo proton spectroscopy in presence of eddy currents , 1990, Magnetic resonance in medicine.

[18]  Stephen M Smith,et al.  Fast robust automated brain extraction , 2002, Human brain mapping.

[19]  René S. Kahn,et al.  GABA and glutamate in schizophrenia: A 7 T 1H-MRS study , 2014, NeuroImage: Clinical.

[20]  Lynn E Eberly,et al.  Test‐retest reproducibility of neurochemical profiles with short‐echo, single‐voxel MR spectroscopy at 3T and 7T , 2016, Magnetic resonance in medicine.

[21]  Terence W Nixon,et al.  High magnetic field water and metabolite proton T1 and T2 relaxation in rat brain in vivo , 2006, Magnetic resonance in medicine.

[22]  Paul A. Bottomley,et al.  4480228 Selective volume method for performing localized NMR spectroscopy , 1985 .

[23]  H. Bruhn,et al.  Localized high‐resolution proton NMR spectroscopy using stimulated echoes: Initial applications to human brain in vivo , 1989, Magnetic resonance in medicine.

[24]  Christoph Juchem,et al.  Dynamic multi-coil technique (DYNAMITE) shimming for echo-planar imaging of the human brain at 7 Tesla , 2015, NeuroImage.

[25]  van Ormondt D,et al.  Cramer-Rao bound expressions for parametric estimation of overlapping peaks: influence of prior knowledge , 2000, Journal of magnetic resonance (San Diego, Calif. 1997 : Print).

[26]  S. Francis,et al.  Applications of multi-nuclear magnetic resonance spectroscopy at 7T. , 2011, World journal of radiology.

[27]  A. Minagar,et al.  Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis , 2011 .

[28]  V. Govindaraju,et al.  Proton NMR chemical shifts and coupling constants for brain metabolites , 2000, NMR in biomedicine.

[29]  U Klose,et al.  Proton MR spectroscopy with metabolite-nulling reveals elevated macromolecules in acute multiple sclerosis. , 2001, Brain : a journal of neurology.

[30]  D. Sokolović,et al.  Aminoguanidine and N-acetyl-cysteine supress oxidative and nitrosative stress in EAE rat brains , 2011, Redox report : communications in free radical research.

[31]  P M Matthews,et al.  Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: Assessment of the load of disease , 1990, Magnetic resonance in medicine.

[32]  Mauro DiNuzzo,et al.  Neurochemical and BOLD Responses during Neuronal Activation Measured in the Human Visual Cortex at 7 Tesla , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[33]  J. Laranjinha,et al.  Glutamate induces release of glutathione from cultured rat astrocytes – a possible neuroprotective mechanism? , 2008, Journal of neurochemistry.

[34]  I. Silver,et al.  Metabolism and role of glutamate in mammalian brain , 1990, Progress in Neurobiology.

[35]  Stephen M. Smith,et al.  Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm , 2001, IEEE Transactions on Medical Imaging.

[36]  David H. Miller,et al.  Energy failure in multiple sclerosis and its investigation using MR techniques , 2011, Journal of Neurology.

[37]  L. Xin,et al.  Investigating the Metabolic Changes due to Visual Stimulation using Functional Proton Magnetic Resonance Spectroscopy at 7 T , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[38]  Shelly C. Lu.  Glutathione synthesis. , 2013, Biochimica et biophysica acta.

[39]  R. Mattson,et al.  Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[40]  T. Fog,et al.  [Multiple sclerosis; review]. , 1954, Maanedsskrift for praktisk laegegerning og social Medicin.

[41]  J. Hayes,et al.  Potential contribution of the glutathione S-transferase supergene family to resistance to oxidative stress. , 1995, Free radical research.

[42]  G. Bloch,et al.  Brain GABA editing without macromolecule contamination , 2001, Magnetic resonance in medicine.

[43]  Peter B Barker,et al.  Reproducibility of brain spectroscopy at 7T using conventional localization and spectral editing techniques , 2013, Journal of magnetic resonance imaging : JMRI.

[44]  Identification and quantitation of phenylalanine in the brain of patients with phenylketonuria by means of localized in vivo 1H magnetic-resonance spectroscopy. , 1995, Journal of magnetic resonance. Series B.

[45]  V. Calabrese,et al.  Changes in cerebrospinal fluid levels of malondialdehyde and glutathione reductase activity in multiple sclerosis. , 1994, International journal of clinical pharmacology research.

[46]  Rolf Gruetter,et al.  MR spectroscopy of the human brain with enhanced signal intensity at ultrashort echo times on a clinical platform at 3T and 7T , 2009, Magnetic resonance in medicine.

[47]  Robin A. de Graaf,et al.  In Vivo NMR Spectroscopy , 2019 .

[48]  Quantification of 1H NMR spectra from human plasma , 2015, Metabolomics.

[49]  Melissa Miranda,et al.  Inhibitory role for GABA in autoimmune inflammation , 2010, Proceedings of the National Academy of Sciences.

[50]  Phil Lee,et al.  Doubly selective multiple quantum chemical shift imaging and T1 relaxation time measurement of glutathione (GSH) in the human brain in vivo , 2013, NMR in biomedicine.

[51]  Dennis W J Klomp,et al.  Short echo time 1H‐MRSI of the human brain at 3T with minimal chemical shift displacement errors using adiabatic refocusing pulses , 2008, Magnetic resonance in medicine.

[52]  Helene Ratiney,et al.  MR spectroscopic imaging of glutathione in the white and gray matter at 7 T with an application to multiple sclerosis. , 2010, Magnetic resonance imaging.

[53]  G J Barker,et al.  Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. , 1994, Brain : a journal of neurology.

[54]  Massimo Filippi,et al.  MR Spectroscopy in Multiple Sclerosis , 2007, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[55]  Li An,et al.  Reliability of 7T 1H‐MRS measured human prefrontal cortex glutamate, glutamine, and glutathione signals using an adapted echo time optimized PRESS sequence: A between‐ and within‐sessions investigation , 2016, Journal of magnetic resonance imaging : JMRI.

[56]  F. Jacques.  Defining the clinical course of multiple sclerosis: The 2013 revisions , 2015, Neurology.

[57]  Peter R Luijten,et al.  Efficient spectral editing at 7 T: GABA detection with MEGA‐sLASER , 2012, Magnetic resonance in medicine.

[58]  A. Mohamed,et al.  Improvement of experimental allergic encephalomyelitis (EAE) by thymoquinone; an oxidative stress inhibitor. , 2003, Biomedical sciences instrumentation.

[59]  N. Logothetis,et al.  1H-MRS of the macaque monkey primary visual cortex at 7 T: strategies and pitfalls of shimming at the brain surface. , 2007, Magnetic resonance imaging.